AU Stock MarketDetailed Quotes

MXCDA MGC Pharmaceuticals Ltd

Watchlist
  • 0.475
  • 0.0000.00%
20min DelayMarket Closed Nov 7 16:00 AET
2.10MMarket Cap-0.07P/E (Static)

MGC Pharmaceuticals Ltd Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
Total revenue
-28.41%3.39M
59.71%4.73M
42.50%2.96M
216.83%2.08M
656.24K
Operating revenue
-28.41%3.39M
59.71%4.73M
42.50%2.96M
216.83%2.08M
--656.24K
Cost of revenue
-33.72%1.94M
76.83%2.92M
-13.23%1.65M
434.01%1.9M
356.64K
Gross profit
-19.85%1.45M
38.12%1.81M
650.24%1.31M
-41.70%174.67K
299.6K
Operating expense
6.70%17.15M
20.11%16.07M
11.70%13.38M
28.28%11.98M
9.34M
Selling and administrative expenses
30.10%13.42M
63.33%10.31M
46.53%6.31M
25.88%4.31M
--3.42M
-Selling and marketing expense
-8.15%926.91K
73.04%1.01M
3.75%583.19K
-2.24%562.13K
--574.98K
-General and administrative expense
34.25%12.49M
62.34%9.3M
52.95%5.73M
31.56%3.75M
--2.85M
Research and development costs
--1.99M
----
----
----
--2.87M
Depreciation amortization depletion
99.34%493.73K
-49.60%247.69K
2.14%491.41K
85.23%481.13K
--259.74K
-Depreciation and amortization
99.34%493.73K
-49.60%247.69K
2.14%491.41K
85.23%481.13K
--259.74K
Other operating expenses
-77.40%1.25M
-16.17%5.51M
-8.54%6.58M
157.67%7.19M
--2.79M
Operating profit
-10.07%-15.7M
-18.16%-14.26M
-2.25%-12.07M
-30.59%-11.8M
-9.04M
Net non-operating interest income (expenses)
-60.60%-337.01K
41.95%-209.84K
-193.32%-361.5K
-163.58%-123.25K
193.85K
Non-operating interest income
----
-96.06%301
-38.13%7.63K
-93.89%12.34K
--201.85K
Non-operating interest expense
60.37%337.01K
-43.07%210.14K
172.26%369.14K
1,594.78%135.58K
--8K
Other net income (expenses)
19.05%-5.1M
-109.52%-6.3M
56.08%-3.01M
-198.18%-6.84M
6.97M
Special income (charges)
6.78%-4.8M
-34.37%-5.15M
25.11%-3.83M
-105.58%-5.12M
---2.49M
-Less:Impairment of capital assets
-6.96%4.64M
--4.98M
----
105.27%5.12M
--2.49M
-Less:Other special charges
-1.27%164.22K
29.73%166.32K
--128.21K
----
----
-Gain on sale of property,plant,equipment
----
----
---3.7M
----
--3.71K
Other non-operating income (expenses)
74.17%-296.07K
-238.52%-1.15M
148.00%827.6K
-118.23%-1.72M
--9.46M
Income before tax
-1.75%-21.13M
-34.54%-20.77M
17.76%-15.44M
-900.33%-18.77M
-1.88M
Income tax
2.02K
0
-27.28K
0
27.32K
Earnings from equity interest net of tax
Net income
-1.76%-21.13M
-30.85%-20.77M
18.06%-15.87M
-722.91%-19.37M
-2.35M
Net income continuous operations
-1.76%-21.13M
-34.77%-20.77M
17.90%-15.41M
-885.98%-18.77M
---1.9M
Net income discontinuous operations
----
----
22.95%-462.64K
-33.37%-600.43K
---450.19K
Noncontrolling interests
26.27%-309.95K
-20,919.20%-420.38K
71.98%-2K
83.97%-7.14K
-44.53K
Net income attributable to the company
-2.34%-20.82M
-28.21%-20.35M
18.04%-15.87M
-738.47%-19.36M
-2.31M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-2.34%-20.82M
-28.21%-20.35M
18.04%-15.87M
-738.47%-19.36M
-2.31M
Diluted earnings per share
10.13%-7.1
4.82%-7.9
40.71%-8.3
-636.84%-14
-1.9
Basic earnings per share
10.13%-7.1
4.82%-7.9
40.71%-8.3
-636.84%-14
-1.9
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019
Total revenue -28.41%3.39M59.71%4.73M42.50%2.96M216.83%2.08M656.24K
Operating revenue -28.41%3.39M59.71%4.73M42.50%2.96M216.83%2.08M--656.24K
Cost of revenue -33.72%1.94M76.83%2.92M-13.23%1.65M434.01%1.9M356.64K
Gross profit -19.85%1.45M38.12%1.81M650.24%1.31M-41.70%174.67K299.6K
Operating expense 6.70%17.15M20.11%16.07M11.70%13.38M28.28%11.98M9.34M
Selling and administrative expenses 30.10%13.42M63.33%10.31M46.53%6.31M25.88%4.31M--3.42M
-Selling and marketing expense -8.15%926.91K73.04%1.01M3.75%583.19K-2.24%562.13K--574.98K
-General and administrative expense 34.25%12.49M62.34%9.3M52.95%5.73M31.56%3.75M--2.85M
Research and development costs --1.99M--------------2.87M
Depreciation amortization depletion 99.34%493.73K-49.60%247.69K2.14%491.41K85.23%481.13K--259.74K
-Depreciation and amortization 99.34%493.73K-49.60%247.69K2.14%491.41K85.23%481.13K--259.74K
Other operating expenses -77.40%1.25M-16.17%5.51M-8.54%6.58M157.67%7.19M--2.79M
Operating profit -10.07%-15.7M-18.16%-14.26M-2.25%-12.07M-30.59%-11.8M-9.04M
Net non-operating interest income (expenses) -60.60%-337.01K41.95%-209.84K-193.32%-361.5K-163.58%-123.25K193.85K
Non-operating interest income -----96.06%301-38.13%7.63K-93.89%12.34K--201.85K
Non-operating interest expense 60.37%337.01K-43.07%210.14K172.26%369.14K1,594.78%135.58K--8K
Other net income (expenses) 19.05%-5.1M-109.52%-6.3M56.08%-3.01M-198.18%-6.84M6.97M
Special income (charges) 6.78%-4.8M-34.37%-5.15M25.11%-3.83M-105.58%-5.12M---2.49M
-Less:Impairment of capital assets -6.96%4.64M--4.98M----105.27%5.12M--2.49M
-Less:Other special charges -1.27%164.22K29.73%166.32K--128.21K--------
-Gain on sale of property,plant,equipment -----------3.7M------3.71K
Other non-operating income (expenses) 74.17%-296.07K-238.52%-1.15M148.00%827.6K-118.23%-1.72M--9.46M
Income before tax -1.75%-21.13M-34.54%-20.77M17.76%-15.44M-900.33%-18.77M-1.88M
Income tax 2.02K0-27.28K027.32K
Earnings from equity interest net of tax
Net income -1.76%-21.13M-30.85%-20.77M18.06%-15.87M-722.91%-19.37M-2.35M
Net income continuous operations -1.76%-21.13M-34.77%-20.77M17.90%-15.41M-885.98%-18.77M---1.9M
Net income discontinuous operations --------22.95%-462.64K-33.37%-600.43K---450.19K
Noncontrolling interests 26.27%-309.95K-20,919.20%-420.38K71.98%-2K83.97%-7.14K-44.53K
Net income attributable to the company -2.34%-20.82M-28.21%-20.35M18.04%-15.87M-738.47%-19.36M-2.31M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -2.34%-20.82M-28.21%-20.35M18.04%-15.87M-738.47%-19.36M-2.31M
Diluted earnings per share 10.13%-7.14.82%-7.940.71%-8.3-636.84%-14-1.9
Basic earnings per share 10.13%-7.14.82%-7.940.71%-8.3-636.84%-14-1.9
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP